DLDaniel Y. Loisance

Daniel Y. Loisance

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Daniel Y. Loisance has a total of 69 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Cardiac assist devices: present status and future opportunities

    by Daniel Loisance

    Over the last 20 years, continuous progress has been made in the technology and clinical applications of mechanical circulatory support systems for the treatment of the most severe forms of cardiac failure. In a few pioneering centers, their efficacy has been demonstrated in selected groups of patients. This experience enables assessment of the state-of-the-art devices and prediction of likely future developments.


  • Risk factor analysis for proximal and distal reoperations after surgery for acute type A aortic dissection

    by Matthias Kirsch, Céline Soustelle, Rémi Houël, Marie Line Hillion, Daniel Loisance


    • 1 January 2002
      • Vol. 186  (1) , 59-71

    [From circulatory support to artificial heart].

    by Daniel Loisance

    Various systems of mechanical circulatory support are now available: para-corporel devices, implantable ventricular assist devices, either portable or fully implantable. They allow treatment in a wide range of clinical indications, from untractable cardiac failure to cardiogenic shock. They are used in 3 different intention to treat: bridging to transplantation, bridging to recovery or definitive permanent implant. They are progressively becoming efficacious alternatives to cardiac transplantation. Their efficacy has reduced the actual need for a total artificial heart, which nevertheless keeps few indications. Various problems technological, clinical, economical and ethical have to be solved before a wide application of the method.

  • Open Access

    Poststernotomy Mediastinitis Due to Staphylococcus aureus: Comparison of Methicillin-Resistant and Methicillin-Susceptible Cases

    by Armand Mekontso-Dessap, Matthias Kirsch, Christian Brun-Buisson, Daniel Loisance

    The objective of the study was to compare the outcome of poststernotomy mediastinitis (PSM) caused by methicillin-resistant and methicillin-susceptib


  • Open Access

    Norepinephrine release after acute brain death abolishes the cardioprotective effects of ischemic preconditioning in rabbit.

    by Fadi Farhat, Daniel Loisance, Jean-Pierre Garnier, Matthias Kirsch

    Objective: Brain death (BD) abolishes the infarct-limiting effect of ischemic preconditioning (IP) in rabbits. We wished to define the role of the norepinephrine storm in this observation. Methods: Rabbits were randomized into six groups of ten animals each. In control group (CTRL), anaesthetized rabbits were subjected to 30 min left coronary marginal branch occlusion and 90 min reperfusion. In CTRL+IP group, anaesthetized rabbits were preconditioned with a 5-min ischemia and 5-min reperfusion sequence before coronary occlusion. In CTRL+NE+IP group, anaesthetized rabbits received a 10 μg/kg norepinephrine injection 90 min before IP. In BD group, rabbits were subjected to 90 min of BD before coronary occlusion. In BD+IP group, brain-dead rabbits were preconditioned before coronary occlusion. In BD+LA+IP group, rabbits received an intra-arterial bolus injection of an alpha and beta adrenoreceptor blocking agent (labetolol, 1 mg/kg) prior to brain death induction and subsequent preconditioning. BD was induced by rapid inflation of an intracranial balloon. At termination of the experiment, left ventricular volume (LVV), myocardial volume at risk (VAR) and infarct volume (IV) were determined with methylene blue and tetrazolium staining, and measured using planimetry. Results: LVV was not significantly different among groups. Myocardial VAR/LVV was not significantly different between groups (CTRL, 22.5 ± 6.9%; CTRL+IP, 23.3 ± 2.2%; CTRL+NE+IP, 25.9 ± 12.7%; BD, 19.9 ± 4.8%; BD+IP, 21.7 ± 3.1%; BD+LA+IP, 23.4 ± 5.8 %; P = NS). IV/VAR was significantly reduced in the CTRL+IP group as compared with CTRL and CTR+NE+IP groups (12.2 ± 1.2 vs. 49.7 ± 1.2 and 49.3 ± 4.7%; P < 0.0001). There was no significant difference in IV/VAR between BD and BD+IP groups. In contrast, IV/VAR was reduced in BD+LA+IP compared to BD and BD+IP groups (13.9 < 5.4 vs. 50.0 < 1.4 and 49.6 < 1.5%; P < 0.001). Conclusion: The loss of infarct-limiting effect of IP in brain-dead rabbits is related to the massive release of norepinephrine that occurs as a consequence of BD.


  • Intestinal Tissue Oxygenation and Tumor Necrosis Factor‐α Release During Systemic Blood Flow Changes in Pigs with Left Ventricular Assist Devices

    by Yasuhiro Uozaki, Walid C. Dihmis, Hidetoshi Yamauchi, Madeleine Moczar, Masatoshi Miyama, Fabien Pasteau, Denis Tixier, Sektiari L. Bambang, Daniel Y. Loisance

    We previously demonstrated that tumor necrosis factor-α (TNF-α) increased following a reduction in systemic blood flow to 60% or less of the original cardiac output using a left ventricular assist device (LVAD). The aim of this study was to investigate the effect of reducing systemic blood flow on tissue oxygenation in the gastrointestinal tract (GIT) and the consequences of this on TNF-α release. LVADs were implanted in 9 pigs. The aorta was clamped, and thus the LVAD flow represented the entire systemic blood flow. Plasma TNF-α of the superior mesenteric vein was measured at baseline and during systemic blood flow changes. Simultaneously, pH, lactate, oxygen delivery index (Do2I), oxygen consumption index (Vo2I), and oxygen extraction (O2ER) in the GIT were measured. The pH decreased and the lactate level increased significantly (p < 0.05) at a systemic blood flow of 50% or less. The Vo2I was positively correlated with Do2I. The O2ER increased significantly (p < 0.05) with reductions in systemic blood flow to 30% or less. There was a significant (p < 0.01) correlation between TNF-α and O2ER at levels higher than 55%. These data demonstrate that the GIT oxygenation is inadequate with a reduction in systemic blood flow to 50% and that GIT oxygenation becomes critical at a reduction of 30%. During LVAD weaning, careful attention must be given to the GIT. The pH and lactate may be good markers of the adequacy of tissue oxygenation in the GIT.


    • 1 January 2001
      • Vol. 185  (7) , 1225

    [Computer-assisted coronary surgery].

    by D Loisance, R Houël, M Kirsch, O Rosanval, D Thebert

    Routine totally endoscopic, beating heart, coronary surgery should be made possible by the use of computer enhanced surgical techniques. It includes a totally endoscopic mammary artery harvesting, a correct exposure and an adequate stabilization of the coronary artery at the anastomotic site, a perfect anastomosis of the mammary artery on the left anterior descending coronary artery using a microsurgical suture technique. This complex surgical protocol will be reached by a step by step approach. The first 20 patients who accepted to be operated with tele-manipulated instruments make the substance of this first report. In 19 cases, the dissection of the internal mammary artery could be performed with an optimal result: the lack of bleeding during the dissection emphasizes the excellent visualization of the operative field and the precision of the dissection. The satisfactory blood flow in the mammary artery at the time of the coronary anastomosis suggests the lack of spasm and confirms the atraumatic dissection. The distal anastomosis of the coronary bypass has been performed through a mid line sternotomy to avoid an excessive prolongation of the operative time. The anatomic conditions and the quality of the vessel wall allowed to perform the coronary anastomosis with the tele-manipulated instruments in nine cases only: in six patients, the mammary artery has been implanted on the descending artery, in three, a venous autograft on the diagonal branch. Our initial clinical experience with this new technique suggests that a very precise and fine surgery can be performed with an acceptable prolongation of the operative time. More experience and further developments in the instrumentation are nevertheless required to allow completion of the entire procedure totally closed chest, on a beating heart.

  • Cardiac troponin I release after open heart surgery: a marker of myocardial protection?

    by Emmanuelle Vermes, Martine Mesguich, Rémi Houel, Céline Soustelle, Paul Le Besnerais, Marie-Line Hillion, Daniel Loisance


  • Open Access

    Long-term mechanical circulatory support with the wearable Novacor left ventricular assist system✩

    by Daniel Y. Loisance, Piet G.M. Jansen, Dereck R. Wheeldon, Peer M. Portner

    Objective: As of July 1st 1999, 36 European patients have lived for more than 1 year supported by the Novacor wearable electric left ventricular assist system (LVAS). All were unresponsive to maximum medical therapy, prior to implantation. These patients offer an unique opportunity to evaluate the feasibility of long-term ambulatory mechanical circulatory support as a therapeutic option for patients in profound cardiac failure. Methods: Data was obtained from the Novacor European Registry. Results: At the time of implantation, median age was 55 (18–67) years. Aetiology was ischemic (9, 25%) or idiopathic (26, 72%) cardiomyopathy, and myocarditis (1, 3%). Median duration of LVAS support was 1.49 (1.03–4.10) years. Eight recipients had LVAS support times ≫2 years, of which two were ≫3 years and one ≫4 years. The median time spent outside the hospital was 1.27 (0.58–3.83) years, representing 82% of the duration of LVAS support. No mechanical failure was observed during the entire observation period. One pump was replaced electively after 3.67 years due to pump driver wear-out. Twelve patients (33%) are currently on support while 17 were transplanted (14, 39%) or weaned (3, 8%). Seven (19%) patients died after a median of 1.24 years circulatory support. Conclusions: Experience with long-term Novacor LVAS recipients has demonstrated effective rehabilitation in this group of patients with refractory advanced heart failure. This suggests that LVAS therapy may offer a safe and realistic option for patients for whom no other effective therapy is available. The patient sub-population that would benefit most from this therapy remains to be defined.


    • 1 February 2000
      • Vol. 93  (2) , 131-8

    [External ventricular support in primary cardiogenic shock].

    by R Houël, E Vermes, P Le Besnerais, M L Hillion, B Alimoussa, D Y Loisance

    Primary cardiogenic shock is a common condition with a high mortality rate. In this indication, mechanical assist plays an important part and has improved a lot over the last decade. The authors report their experience with the same assist device in patients with primary cardiogenic shock. Nineteen patients (9 dilated cardiomyopathies, 7 myocardial infarctions, 2 myocardities, 1 undetermined) were treated with an external mechanical ventricular assist device (Thoratec, Berkeley, U.S.). Fourteen patients received a biventricular assist and 5 had a uni-left ventricular assist device. Four of the 19 patients were completely weaned off their ventricular assist after 13, 27, 36 and 94 days, respectively. Ten patients underwent transplantation after an average of 43 days (range 8-95 days). Of the 19 patients, 7 had a portable console allowing autonomous ambulation. Five patients died under mechanical assistance (26.9%) and 3 patients died after transplantation. Three patients required temporary haemodialysis; 4 suffered embolic complications; 4 had mediastinal haemorrhages; 4 had bleeding from other sites, and 6 suffered from late tamponnade. Fourteen patients had at least one infectious episode. The authors conclude that, in patients referred for severe primary cardiogenic shock, the implantation of an external biventricular assist is a reliable option, allowing sequential weaning or being a bridge to transplantation in non-dependent patients, providing they are severely selected.